AORTIC VALVE DISEASE 2
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic variants in SMAD6 are associated with a complex cardiovascular phenotype.
|
30963242 |
2019 |
AORTIC VALVE DISEASE 2
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation.
|
22275001 |
2012 |
AORTIC VALVE DISEASE 2
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation.
|
22275001 |
2012 |
AORTIC VALVE DISEASE 2
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
AORTIC VALVE DISEASE 2
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Bicuspid aortic valve
|
0.650 |
Biomarker
|
disease |
BEFREE |
In conclusion, we identified a novel SMAD6 variant causing a severely calcified BAV and TAA, which contributes to our understanding of the clinical and genetic background of SMAD6-related BAV.
|
30848080 |
2019 |
Bicuspid aortic valve
|
0.650 |
GeneticVariation
|
disease |
BEFREE |
Rare heterozygous variants in SMAD6 have been identified as a significant genetic contributor to bicuspid aortic valve-associated thoracic aortic aneurysm on one hand and non-syndromic midline craniosynostosis on the other.
|
30963242 |
2019 |
Bicuspid aortic valve
|
0.650 |
Biomarker
|
disease |
CTD_human |
Causative gene mutations (for example, NOTCH1, SMAD6) are known for ≤1% of nonsyndromic BAV cases with and without AscAA<sup>5-8</sup>, impeding mechanistic insight and development of therapeutic strategies.
|
30455415 |
2019 |
Bicuspid aortic valve
|
0.650 |
Biomarker
|
disease |
BEFREE |
Causative gene mutations (for example, NOTCH1, SMAD6) are known for ≤1% of nonsyndromic BAV cases with and without AscAA<sup>5-8</sup>, impeding mechanistic insight and development of therapeutic strategies.
|
30455415 |
2019 |
Bicuspid aortic valve
|
0.650 |
GeneticVariation
|
disease |
BEFREE |
Although only 14% of the TAA patients also presented BAV, all novel likely pathogenic SMAD6 variants (N = 7) were identified in BAV/TAA individuals, further establishing the role of SMAD6 variants to the aetiology of BAV/TAA and revealing limited contribution to TAA development in patients with a tricuspid aortic valve.
|
30796334 |
2019 |
Bicuspid aortic valve
|
0.650 |
GeneticVariation
|
disease |
BEFREE |
Up to date, three genes, NOTCH1, GATA5 and SMAD6, have been linked to the isolated form of BAV.
|
29162281 |
2018 |
Bicuspid aortic valve
|
0.650 |
GermlineCausalMutation
|
disease |
ORPHANET |
Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation.
|
22275001 |
2012 |
Bicuspid aortic valve
|
0.650 |
Biomarker
|
disease |
HPO |
|
|
|
Scaphycephaly
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic Aneurysm Cohort: SMAD6 as an Important Contributor.
|
28659821 |
2017 |
Metopic synostosis
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic Aneurysm Cohort: SMAD6 as an Important Contributor.
|
28659821 |
2017 |
CRANIOSYNOSTOSIS 7
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic Aneurysm Cohort: SMAD6 as an Important Contributor.
|
28659821 |
2017 |
CRANIOSYNOSTOSIS 7
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and common BMP2 alleles.
|
27606499 |
2016 |
Scaphycephaly
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Metopic synostosis
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Craniosynostosis
|
0.440 |
GeneticVariation
|
disease |
BEFREE |
SMAD6 Genotype Predicts Neurodevelopment in Non-syndromic Craniosynostosis.
|
31592950 |
2020 |
Craniosynostosis
|
0.440 |
GeneticVariation
|
disease |
BEFREE |
Rare heterozygous variants in SMAD6 have been identified as a significant genetic contributor to bicuspid aortic valve-associated thoracic aortic aneurysm on one hand and non-syndromic midline craniosynostosis on the other.
|
30963242 |
2019 |
Craniosynostosis
|
0.440 |
GeneticVariation
|
disease |
BEFREE |
While significantly reduced penetrance of craniosynostosis has been reported for the SMAD6 variants as such, near-complete penetrance is reached upon co-occurrence with a common BMP2 SNP risk allele.
|
30796334 |
2019 |
Craniosynostosis
|
0.440 |
Biomarker
|
disease |
BEFREE |
Although at least 50 nuclear genes including FGFR2, TWIST1, TCF12, and SMAD6 were identified as causative of craniosynostosis; only 25% of the patients can be genetically diagnosed.
|
30088857 |
2018 |
Craniosynostosis
|
0.440 |
Biomarker
|
disease |
CTD_human |
|
|
|
Craniosynostosis
|
0.440 |
Biomarker
|
disease |
HPO |
|
|
|